Blog
Nolvadex vs Clomid for PCT: Which SERM Fits Your Recovery Plan?
The short answer: Nolvadex (tamoxifen) and Clomid (clomiphene) are both selective estrogen receptor modulators (SERMs) used in post-cycle therapy (PCT), but they are not interchangeable. Nolvadex is stronger when gynecomastia (gyno) is the main concern, because it blocks estrogen receptors directly in breast tissue. Clomid tends to raise luteinizing hormone (LH) and follicle-stimulating hormone (FSH) more strongly, making it the more common pick for restoring natural testosterone and fertility.
This guide compares the two drugs head to head — how they work, the protocols people commonly discuss, their side effects, and how to decide — so you can have an informed conversation with a clinician rather than guessing. Nothing here is a prescription: PCT drugs are prescription medicines with real risks, and bloodwork plus medical advice should come before any protocol.
Why PCT Exists at All
When you use anabolic steroids, your body senses the flood of androgens and shuts down its own production: the hypothalamus stops releasing gonadotropin-releasing hormone (GnRH), the pituitary stops releasing LH and FSH, and the testes stop making testosterone. That quiet hypothalamic-pituitary-testicular axis (HPTA) is why coming off a cycle can feel so rough — low energy, low libido, depressed mood, and muscle loss while your own testosterone is still near zero.
PCT aims to restart that axis faster than it would restart on its own. SERMs block estrogen receptors in the hypothalamus and pituitary; with estrogen’s “stop” signal muted, the brain releases more GnRH, LH, and FSH, and the testes resume making testosterone. A 2023 study of 641 men attending a clinic after stopping anabolic steroids found that men who reported using PCT reached normalized hormones in a median of 13 weeks, versus 26 weeks without PCT — although only 48.2% had fully normalized, a reminder that recovery is neither guaranteed nor quick.
Nolvadex (Tamoxifen) at a Glance
Tamoxifen was developed as a breast cancer drug, and that origin explains its signature strength: potent estrogen-receptor blockade in breast tissue. In PCT, that makes Nolvadex 20mg tablets the go-to option when gyno symptoms — tenderness, itching, or a lump behind the nipple — appear during or after a cycle. It does not lower blood estrogen like an aromatase inhibitor; it blocks estrogen at specific receptors.
Tamoxifen also raises LH, FSH, and testosterone in men. In a classic 1983 study, men with low sperm counts who took tamoxifen 20 mg per day saw their mean sperm concentration and total sperm count roughly double, alongside significant rises in testosterone and FSH. Its half-life is about 5 to 7 days, so levels build steadily — well suited to a multi-week PCT. Commonly discussed dosing is 20 mg per day for 4 to 6 weeks, sometimes starting at 40 mg per day when gyno is active.
Clomid (Clomiphene) at a Glance
Clomiphene is a mixture of two isomers, enclomiphene and zuclomiphene, and acts more strongly at the hypothalamus and pituitary than at breast tissue. That is why it is often called the better “restart” drug: it pushes LH and FSH harder, and through them, testosterone. A 2025 meta-analysis of randomized trials found SERM therapy (clomiphene and enclomiphene) raised total testosterone by about 274 ng/dL versus placebo, with LH up about 4.7 IU/L and FSH up about 4.6 IU/L.
That stronger gonadotropin push comes with a trade-off. Clomiphene is the SERM most associated with visual side effects — blurred vision, floaters, or light sensitivity — and with mood swings and irritability, often attributed to the longer-lingering zuclomiphene isomer. Its half-life is also about 5 to 7 days, so side effects can persist after the last dose. Commonly discussed dosing is 50 mg per day for 4 weeks; higher doses tend to bring more side effects without clearly better recovery.
Nolvadex vs Clomid: Head-to-Head Comparison
| Feature | Nolvadex (tamoxifen) | Clomid (clomiphene) |
|---|---|---|
| Drug class | SERM | SERM (enclomiphene + zuclomiphene) |
| Main PCT strength | Blocking estrogen at breast tissue — best for gyno | Strong LH/FSH push — best for testosterone restart |
| Effect on testosterone | Moderate rise via LH/FSH | Stronger average rise in trials (about +274 ng/dL vs placebo for SERMs overall) |
| Effect on fertility markers | Sperm count roughly doubled in a 1983 study at 20 mg/day | Higher FSH/LH; widely used for male hypogonadism and fertility |
| Half-life | About 5–7 days | About 5–7 days (zuclomiphene lingers longer) |
| Commonly discussed PCT dose | 20 mg/day for 4–6 weeks | 50 mg/day for 4 weeks |
| Signature side effects | Hot flashes, blood-clot risk (rare but serious), possible vision changes | Visual disturbances, mood swings, headaches |
| Best for | Gyno prevention or treatment, milder cycles | Heavier suppression, fertility-focused recovery |
Common PCT Protocols People Discuss
There is no clinically approved PCT protocol for steroid users — every protocol below is a community convention, not a medical guideline. The three patterns below cover most of what you will see discussed.
Nolvadex only. 20 mg per day for 4 to 6 weeks — the simplest option, and a reasonable default after a moderate testosterone-only cycle, especially if gyno was an issue. If gyno symptoms are active, some users start at 40 mg per day, then drop to 20 mg.
Clomid only. 50 mg per day for 4 weeks, occasionally starting at 100 mg per day for the first week. Chosen when restarting testosterone and fertility after a heavier cycle is the priority. If visual or mood side effects appear, lower the dose or stop — do not push through.
Combined Nolvadex + Clomid. For example, Clomid 50 mg per day plus Nolvadex 20 mg per day for 4 weeks. Clomid drives the LH/FSH restart while Nolvadex guards breast tissue. This is the most aggressive option, typically reserved for long or multi-compound cycles, and it stacks both side-effect profiles — it is not a “more is better” default.
Timing matters as much as the drug: PCT should only start once the steroids from your cycle have mostly cleared — roughly 2 weeks after the last injection of a long ester like testosterone enanthate, or a few days after short esters or orals. Our earlier guide on why post-cycle therapy matters after a steroid cycle covers this window in more detail.
Side Effects: What to Watch For
Both drugs are generally tolerated for short courses, but both carry rare serious risks. Stop and seek medical care for persistent vision changes, severe headaches, leg swelling or pain, chest pain, or shortness of breath.
| Side effect | Nolvadex | Clomid |
|---|---|---|
| Visual disturbances | Possible, less commonly reported | More characteristic — blurring, floaters, light sensitivity |
| Mood / emotional effects | Less prominent | Mood swings and irritability commonly reported |
| Hot flashes / sweats | Common | Occasional |
| Headache, nausea | Occasional | Occasional |
| Blood clots | Rare but serious documented risk | Rare |
| Liver strain | Rare, with long-term use mainly | Rare |
Which One Should You Choose?
Choose Nolvadex first if gyno is your main worry, your cycle was moderate, or you reacted badly to Clomid before. Its breast-tissue blockade is unmatched among PCT drugs, and its day-to-day side effects are usually gentler. For many testosterone-only cycles, Nolvadex alone is enough.
Choose Clomid first if restoring testosterone and fertility after a long or heavy cycle is the priority, and you tolerate it well. Its stronger LH/FSH signal is why fertility clinics use clomiphene for male hypogonadism. If vision or mood side effects show up, switch to Nolvadex rather than enduring them.
Consider both if you ran a long, multi-compound cycle and want both the restart push and the gyno cover — accepting the combined side-effect load. Skip self-directed PCT and see a doctor if you have a history of blood clots, eye disease, liver disease, or depression, or if a previous recovery took many months; some men need medically supervised recovery, sometimes with hCG or testosterone therapy instead of, or alongside, a SERM.
Bloodwork: The Only Way to Know It Worked
Symptoms lie: you can feel fine with testosterone still low, or terrible while your numbers are recovering. The minimum sensible panel — taken at baseline, at the end of PCT, and again 6 to 8 weeks later — covers total testosterone, LH, FSH, estradiol, and a basic liver panel, plus a semen analysis if fertility matters to you. If LH and FSH are back in range but testosterone is still low, or nothing has moved after 8 to 12 weeks, that is a doctor conversation, not a reason to extend PCT indefinitely.
For whether you need PCT at all, see our guide on whether you need PCT after a testosterone cycle. Clomid 50mg tablets are the standard strength most PCT discussions use, just as 20 mg is the standard Nolvadex tablet.
Frequently Asked Questions
Can I take Nolvadex and Clomid together for PCT?
Yes — combined protocols are common after heavy cycles, typically Clomid 50 mg per day plus Nolvadex 20 mg per day for 4 weeks. It covers both restart and gyno protection, but combines both side-effect profiles, so it is not automatically better than either drug alone.
Which is better for gyno, Nolvadex or Clomid?
Nolvadex, clearly. Tamoxifen blocks estrogen receptors in breast tissue directly; Clomid acts mainly at the brain and pituitary and offers much less breast-tissue protection.
Does Clomid really cause vision problems?
Visual disturbances — blurring, floaters, and light sensitivity — are a recognized clomiphene side effect and the most common reason users stop it. They usually resolve after stopping, but any persistent change should be checked by an eye professional promptly.
How long until testosterone recovers after PCT?
There is no fixed timeline. In the 2023 clinic study, men who used PCT took a median of 13 weeks from cessation to normalized hormones, versus 26 weeks without PCT — and only about half had normalized at all. Bloodwork at the end of PCT and again 6 to 8 weeks later is the only reliable way to track your recovery.
References
- Hohl A, Chavez MP, Pasqualotto E, Ferreira ROM, van de Sande-Lee S, Ronsoni MF. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Archives of Endocrinology and Metabolism. 2025;69(5):e250093. PubMed
- Buvat J, Ardaens K, Lemaire A, Gauthier A, Gasnault JP, Buvat-Herbaut M. Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen. Fertility and Sterility. 1983;39(5):700–703. PubMed
- Grant B, Campbell J, Pradeep A, Burns AD, Bassett P, Abbara A, Saket P, Minhas S, Dhillo WS, McVeigh J, Bhasin S, Jayasena CN. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study. European Journal of Endocrinology. 2023;189(6):601–610. PubMed
Disclaimer: This article is for educational purposes only. It is not medical advice and does not recommend any prescription drug or controlled substance. Tamoxifen and clomiphene are prescription medicines with serious risks; speak with a qualified healthcare professional before any decision about post-cycle therapy, and seek urgent care for vision changes, chest pain, leg swelling, or severe headaches.
